References
- Glenner GG. Amyloid deposits and amyloidosis: the beta-fibrillose (second of two parts). N Engl J Med. 1980;302(24):1333–1343
- Lachmann HJ, Goodman HJ, Gilbertson JA, et al. Natural history and outcome in systemic AA amyloidosis. N Engl J Med. 2007;356(23):2361–2371
- Pinney JH, Hawkins PN. Amyloidosis. Ann Clin Biochem. 2012;49(Pt 3):229–241
- Ben-Chetrit E, Levy M. Familial Mediterranean fever. Lancet. 1998;351(9103):659–664
- Sohar E, Gafni J, Pras M, et al. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med. 1967;43(2):227–253
- Ben-Chetrit E, Ben-Chetrit A, Berkun Y, et al. Pregnancy outcomes in women with familial Mediterranean fever receiving colchicine: is amniocentesis justified? Arthritis Care Res (Hoboken). 2010;62(2):143–148
- Ben-Chetrit E, Levy M. Reproductive system in familial Mediterranean fever: an overview. Ann Rheum Dis. 2003;62(10):916–919
- Michael O, Goldman RD, Koren G, et al. Safety of colchicine therapy during pregnancy. Can Fam Physician. 2003;49:967–969
- Rabinovitch O, Zemer D, Kukia E, et al. Colchicine treatment in conception and pregnancy: two hundred thirty-one pregnancies in patients with familial Mediterranean fever. Am J Reprod Immunol. 1992;28(3–4):245–246
- Zemer D, Pras M, Sohar E, et al. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med. 1986;314(16):1001–1005
- Livneh A, Zemer D, Langevitz P, et al. Colchicine treatment of AA amyloidosis of familial Mediterranean fever. An analysis of factors affecting outcome. Arthritis Rheum. 1994;37(12):1804–1811
- Livneh A, Cabili S, Zemer D, et al. Effect of pregnancy on renal function in amyloidosis of familial Mediterranean fever. J Rheumatol. 1993;20(9):1519–1523
- Lamminpaa R, Vehvilainen-Julkunen K, Gissler M, et al. Preeclampsia complicated by advanced maternal age: a registry-based study on primiparous women in Finland 1997–2008. BMC Pregn Childbirth. 2012;12:47